MedPath

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Registration Number
NCT00089323
Lead Sponsor
NSABP Foundation Inc
Brief Summary

RATIONALE: Diagnostic procedures that detect tumor cells in the bone marrow may help doctors predict disease recurrence and plan more effective treatment.

PURPOSE: This clinical trial is studying how well diagnostic procedures work in detecting tumor cells in the bone marrow of patients who have undergone surgery for stage I, stage II, or stage IIIA breast cancer.

Detailed Description

OBJECTIVES:

Primary

* Determine the relative risk of death associated with the presence of tumor cells in the bone marrow of patients with stage I, II, or IIIA breast cancer undergoing surgery and bone marrow analysis using multicolor fluorescence immunocytochemistry and bright field immunocytochemistry.

Secondary

* Compare multicolor fluorescence immunocytochemistry vs bright field immunocytochemistry in the detection of bone marrow micrometastases in these patients.

OUTLINE: This is a multicenter study.

Patients undergo bone marrow aspiration during surgical resection of the primary tumor. Bone marrow cells and tumor samples are analyzed using bright field immunocytochemistry and multicolor fluorescence immunocytochemistry.

Patients are followed every 12 months for up to 10 years.

PROJECTED ACCRUAL: A total of 1,634 patients will be accrued for this study within 3 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1630
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Overall survivalFrom time of randomization to death from any cause through 10 years.
Secondary Outcome Measures
NameTimeMethod
Tumor cell presence as measured by bright-field and multicolor fluorescence immunocytochemical methodsAs detected at time of analysis.

Trial Locations

Locations (53)

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

Tunnell Cancer Center at Beebe Medical Center

🇺🇸

Lewes, Delaware, United States

CCOP - Christiana Care Health Services

🇺🇸

Newark, Delaware, United States

Morton Plant Hospital

🇺🇸

Clearwater, Florida, United States

St. Vincent's Medical Center

🇺🇸

Jacksonville, Florida, United States

Lakeland Regional Cancer Center at Lakeland Regional Medical Center

🇺🇸

Lakeland, Florida, United States

Union Hospital of Cecil County

🇺🇸

Elkton, Maryland, United States

CCOP - Montana Cancer Consortium

🇺🇸

Billings, Montana, United States

Northern Rockies Radiation Oncology Center

🇺🇸

Billings, Montana, United States

St. Vincent Healthcare Cancer Care Services

🇺🇸

Billings, Montana, United States

Scroll for more (43 remaining)
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
🇺🇸Little Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.